LOG IN
SIGN UP
MARKET
LNTH
LNTH
Lantheus Holding
NASDAQ
Real-time Quotes | Nasdaq Last Sale
65.14
-0.04
-0.06%
Opening 11:12 05/26 EDT
OPEN
67.86
PREV CLOSE
65.18
HIGH
69.42
LOW
64.09
VOLUME
619.80K
TURNOVER
29.30M
52 WEEK HIGH
69.74
52 WEEK LOW
19.30
MARKET CAP
4.47B
P/E (TTM)
-113.5239
1D
5D
1M
3M
1Y
5Y
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?
Style Box ETF report for FYX
Zacks · 3d ago
Wall Street Analysts Predict a 44% Upside in Lantheus Holdings (LNTH): Here's What You Should Know
The consensus price target hints at a 44.2% upside potential for Lantheus Holdings (LNTH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witne...
Zacks · 6d ago
Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now?
Smart Beta ETF report for FYX
Zacks · 05/18 10:20
Insider Sell: Lantheus Holdings
MT Newswires · 05/17 17:37
Lantheus Holdings To Host Investor Day On Tuesday, May 17, 2022, Starting At 9 a.m. EDT
Lantheus Holdings, Inc. (the “Company”) (NASDAQ:LNTH), will host its Inaugural Investor Day at the Nasdaq MarketSite on Tuesday, May 17, beginning at 9:00 a.m. EDT. Members of Lantheus’ management team
Benzinga · 05/16 20:58
Lantheus Hosts Inaugural Investor Day
Lantheus Outlines Sustainable and Profitable Growth Strategy; Introduces Long-Term Financial TargetsNORTH BILLERICA, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), will host its Inaugural Investor Day at the...
GlobeNewswire · 05/16 20:30
Lantheus Holdings (LNTH) Just Overtook the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Zacks · 05/16 13:35
Lantheus Holdings (LNTH) Is a Great Choice for "Trend" Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Lantheus Holdings (LNTH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks · 05/16 12:50
No Data
Learn about the latest financial forecast of LNTH. Analyze the recent business situations of Lantheus Holding through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 5 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
40.00%Strong Buy
60.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average LNTH stock price target is 91.80 with a high estimate of 100.00 and a low estimate of 80.00.
Current 65.14
EPS
Actual
Estimate
0.240.480.730.97
Institutional Holdings
Institutions: 403
Institutional Holdings: 75.61M
% Owned: 110.16%
Shares Outstanding: 68.63M
TypeInstitutionsShares
Increased
62
6.57M
New
88
7.33M
Decreased
100
11.98M
Sold Out
8
171.91K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.43%
Healthcare Equipment & Supplies
+0.72%
Key Executives
Non-Executive Chairman/Independent Director
Brian Markison
President/Chief Executive Officer/Director
Mary Heino
Chief Financial Officer/Treasurer
Robert Marshall
Chief Human Resource Officer
Vivian Yao
Senior Vice President/General Counsel/Secretary
Daniel Niedzwiecki
Senior Vice President
Carol Walker
Vice President
Linda Lennox
Other
Paul Blanchfield
Other
Etienne Montagut
Other
Jean-Claude Provost
Independent Director
Minnie Baylor-Henry
Independent Director
Gerard Ber
Independent Director
Samuel Leno
Independent Director
Heinz Maeusli
Independent Director
Julie Mchugh
Independent Director
Gary Pruden
Independent Director
James Thrall
No Data
No Data
About LNTH
Lantheus Holdings, Inc. is a provider of imaging diagnostics, targeted therapeutics, and artificial intelligence solutions to Find, Fight and Follow serious medical conditions. It operates through two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its agents and products throughout the United States. The International Segment operations consist of direct distribution in Canada and Puerto Rico, as well as third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific and Latin America and its EXINI business in Sweden. The Company sells its products to radio pharmacies, PET manufacturing facilities (PMFs), integrated delivery networks, hospitals, clinics and group practices. Its commercial portfolio includes DEFINITY, TechneLite, NEUROLITE, RELISTOR, Xenon-133, Cardiolite, Gallium-67, Thallium-201, AZEDRA, QUADRAMET, Cobalt and Automated Bone Scan Index (aBSI).
Webull offers kinds of Lantheus Holdings Inc stock information, including NASDAQ:LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.